HENRY FORD HEALTH SYSTEM
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1915-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.henryford.com
Randomized Trial of Suicide Gene Therapy and Prostate Cancer
Phase 2
Completed
- Conditions
- Prostate Cancer
- Interventions
- Radiation: IMRTBiological: Ad5-yCD/mutTKSR39rep-ADP
- First Posted Date
- 2007-12-31
- Last Posted Date
- 2016-03-17
- Lead Sponsor
- Henry Ford Health System
- Target Recruit Count
- 44
- Registration Number
- NCT00583492
- Locations
- 🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
🇺🇸Henry Ford Health System, Detroit, Michigan, United States
RCT of the Cutting Balloon Versus a High Pressure Balloon for the Treatment of Arteriovenous Fistula Stenoses
Not Applicable
Withdrawn
- Conditions
- Stenosis
- Interventions
- Procedure: CUTTING BALLOON ANGIOPLASTYProcedure: Balloon angioplasty
- First Posted Date
- 2007-10-12
- Last Posted Date
- 2022-03-21
- Lead Sponsor
- Henry Ford Health System
- Registration Number
- NCT00543348
- Locations
- 🇺🇸
Henry Ford Hospital, Detroit, Michigan, United States
Study on the Effect of NdYag Laser for the Treatment of Hidradenitis Suppurativa
Not Applicable
Completed
- Conditions
- Hidradenitis Suppurativa
- First Posted Date
- 2007-06-29
- Last Posted Date
- 2024-04-30
- Lead Sponsor
- Henry Ford Health System
- Target Recruit Count
- 20
- Registration Number
- NCT00494351
- Locations
- 🇺🇸
Department of Dermatology, Henry Ford Medical Center, 3031 West Grand Boulevard,, Detroit, Michigan, United States
Impact of Long Wavelength Ultraviolet (UVA) and Visible Light on Melanocompetent Skin
Completed
- Conditions
- Healthy
- First Posted Date
- 2007-05-25
- Last Posted Date
- 2024-04-30
- Lead Sponsor
- Henry Ford Health System
- Target Recruit Count
- 22
- Registration Number
- NCT00478751
- Locations
- 🇺🇸
Department of Dermatology, Henry Ford Medical Center, 3031 West Grand Boulevard,, Detroit, Michigan, United States
Using Information Technology to Improve Asthma Adherence
Not Applicable
Completed
- Conditions
- AsthmaPatient Compliance
- Interventions
- Behavioral: Feedback of patient adherence informationBehavioral: Active control group
- First Posted Date
- 2007-04-11
- Last Posted Date
- 2010-08-17
- Lead Sponsor
- Henry Ford Health System
- Target Recruit Count
- 2698
- Registration Number
- NCT00459368
- Locations
- 🇺🇸
Henry Ford Health System, Detroit, Michigan, United States
Sildenafil (Viagra) Treatment of Subacute Ischemic Stroke
- First Posted Date
- 2007-03-27
- Last Posted Date
- 2011-03-16
- Lead Sponsor
- Henry Ford Health System
- Target Recruit Count
- 20
- Registration Number
- NCT00452582
- Locations
- 🇺🇸
Henry Ford Hospital, Detroit, Michigan, United States
Erlotinib (Tarceva) During First Line Standard Platinum Containing Chemo for Advanced Squamous Cell Head and Neck Cancer
- First Posted Date
- 2007-03-16
- Last Posted Date
- 2025-03-18
- Lead Sponsor
- Henry Ford Health System
- Target Recruit Count
- 6
- Registration Number
- NCT00448240
Study Combining Suicide Gene Therapy With Chemoradiotherapy in the Treatment of Non-Metastatic Pancreatic Adenocarcinoma
Phase 1
Terminated
- Conditions
- Pancreatic Cancer
- Interventions
- Genetic: Ad5-yCD/mutTKSR39rep-ADP
- First Posted Date
- 2006-12-25
- Last Posted Date
- 2011-06-23
- Lead Sponsor
- Henry Ford Health System
- Target Recruit Count
- 8
- Registration Number
- NCT00415454
- Locations
- 🇺🇸
Henry Ford Health System, Detroit, Michigan, United States
Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo
Not Applicable
Completed
- Conditions
- Vitiligo
- First Posted Date
- 2006-08-22
- Last Posted Date
- 2024-04-30
- Lead Sponsor
- Henry Ford Health System
- Target Recruit Count
- 17
- Registration Number
- NCT00367224
- Locations
- 🇺🇸
Department of Dermatology/Henry Ford Hospital, Detroit, Michigan, United States
Pregabalin for Abdominal Pain From Adhesions
Phase 4
Terminated
- Conditions
- Abdominal PainSurgical Adhesions
- Interventions
- Drug: Placebo first followed by open label pregabalin
- First Posted Date
- 2006-04-04
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Henry Ford Health System
- Target Recruit Count
- 18
- Registration Number
- NCT00310765
- Locations
- 🇺🇸
Henry Ford Health System, West Bloomfield, Michigan, United States
© Copyright 2025. All Rights Reserved by MedPath